|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,010.31 USD | -0.41% |
|
-6.06% | +30.87% |
| 11:02am | Eli Lilly, Pfizer Secure Inclusion in Chinese Private Health Insurance Catalog | MT |
| 05/12 | India's Healthify eyes more weight-loss drugmaker tie-ups after Novo Nordisk pact | RE |
| Capitalization | 90TCr 78TCr 73TCr 68TCr 1,25400Cr 81,41400Cr 1,36400Cr 8,52000Cr 3,29000Cr 38,45100Cr 3,39500Cr 3,32300Cr 1,40,59300Cr | P/E ratio 2025 * |
44.2x | P/E ratio 2026 * | 31.9x |
|---|---|---|---|---|---|
| Enterprise value | 93TCr 80TCr 75TCr 70TCr 1,28900Cr 83,65700Cr 1,40200Cr 8,75500Cr 3,38100Cr 39,51000Cr 3,48900Cr 3,41400Cr 1,44,46500Cr | EV / Sales 2025 * |
14.6x | EV / Sales 2026 * | 12.1x |
| Free-Float |
99.81% | Yield 2025 * |
0.59% | Yield 2026 * | 0.66% |
Last Transcript: Eli Lilly and Company
| 1 day | -0.41% | ||
| 1 week | -6.06% | ||
| Current month | -6.06% | ||
| 1 month | +7.77% | ||
| 3 months | +38.93% | ||
| 6 months | +31.23% | ||
| Current year | +30.87% |
| 1 week | 1,004 |  | 1,084.15 |
| 1 month | 938.4 | | 1,111.99 |
| Current year | 623.78 | | 1,111.99 |
| 1 year | 623.78 | | 1,111.99 |
| 3 years | 302.14 | | 1,111.99 |
| 5 years | 146.91 | | 1,111.99 |
| 10 years | 64.18 | | 1,111.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Ricks
CEO | Chief Executive Officer | 57 | 01/01/2017 |
Ruth Gimeno
PSD | President | - | - |
Lucas Montarce
DFI | Director of Finance/CFO | 48 | 09/09/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Jon Fyrwald
BRD | Director/Board Member | 65 | 01/01/2005 |
Ralph Alvarez
BRD | Director/Board Member | 69 | 01/04/2009 |
| Director/Board Member | 53 | 12/12/2011 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 6.49% | 26 M€ | +11.73% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.41% | -6.06% | +22.21% | +174.14% | 90TCr | |
| -0.27% | -2.41% | +35.24% | +14.67% | 49TCr | |
| -1.15% | -0.71% | +28.32% | +38.09% | 40TCr | |
| +0.26% | +1.14% | +20.97% | +1.87% | 33TCr | |
| +0.58% | -2.73% | +27.58% | +21.90% | 28TCr | |
| +0.19% | +2.49% | +19.23% | +25.56% | 26TCr | |
| -1.16% | -4.87% | -3.27% | -8.45% | 25TCr | |
| +1.24% | -2.33% | -60.59% | -30.82% | 21TCr | |
| -3.02% | -4.51% | +21.03% | +16.45% | 18TCr | |
| -1.14% | -3.67% | +31.57% | +37.81% | 15TCr | |
| Average | -0.49% | -2.37% | +14.23% | +29.12% | 34.47TCr | |
| Weighted average by Cap. | -0.40% | -2.83% | +18.23% | +56.02% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 6.35TCr 5.46TCr 5.12TCr 4.77TCr 8.81TCr 5,71900Cr 9.58TCr 60TCr 23TCr 2,70100Cr 24TCr 23TCr 9,87600Cr | 7.58TCr 6.51TCr 6.1TCr 5.69TCr 11TCr 6,82100Cr 11TCr 71TCr 28TCr 3,22100Cr 28TCr 28TCr 11,77900Cr |
| Net income | 2.04TCr 1.75TCr 1.64TCr 1.53TCr 2.82TCr 1,83400Cr 3.07TCr 19TCr 7.41TCr 87TCr 7.65TCr 7.48TCr 3,16600Cr | 2.78TCr 2.39TCr 2.24TCr 2.09TCr 3.86TCr 2,50500Cr 4.2TCr 26TCr 10TCr 1,18300Cr 10TCr 10TCr 4,32600Cr |
| Net Debt | 2.49TCr 2.14TCr 2.01TCr 1.87TCr 3.45TCr 2,24300Cr 3.76TCr 23TCr 9.06TCr 1,05900Cr 9.35TCr 9.15TCr 3,87300Cr | 875.21Cr 752.33Cr 704.77Cr 656.9Cr 1.21TCr 79TCr 1.32TCr 8.24TCr 3.18TCr 37TCr 3.28TCr 3.21TCr 1,36000Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/25/05 | 1,010.31 $ | -0.41% | 25,02,066 |
| 04/25/04 | 1,014.49 $ | -1.85% | 38,54,911 |
| 03/25/03 | 1,033.56 $ | -1.20% | 34,47,003 |
| 02/25/02 | 1,046.12 $ | -1.11% | 32,79,960 |
| 01/25/01 | 1,057.89 $ | -1.63% | 30,70,153 |
Delayed Quote Nyse, December 06, 2025 at 02:30 am IST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- LLY Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition